Status:
COMPLETED
DHA Supplementation and Pregnancy Outcome
Lead Sponsor:
Susan Carlson, PhD
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Pregnancy
Eligibility:
FEMALE
16-36 years
Phase:
PHASE3
Brief Summary
The purpose of the study is to determine if increasing DHA intake during pregnancy can increase gestation duration and enhance infant and childhood outcomes related to visual acuity, stereoacuity, att...
Detailed Description
Although numerous trials show benefits of postnatal DHA supplementation for visual acuity and others show benefits for cognitive function and/or attention, studies of increased DHA exposure during fet...
Eligibility Criteria
Inclusion
- Pregnant 8-20 wks at enrollment
- single fetus
- BMI \<40
Exclusion
- diabetes (Type I, ii, GDM)
- hypertension (primary, PIH, preeclampsia/eclampsia)
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00266825
Start Date
January 1 2006
End Date
October 1 2011
Last Update
March 14 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
2
Truman Medical Center
Kansas City, Missouri, United States, 64108